Who is sponsoring NCT04547374?

NCT04547374 is sponsored by Geisinger Clinic.

What drugs are being tested in NCT04547374?

Interventions in NCT04547374: GaH Intervention.

What condition does NCT04547374 study?

NCT04547374 studies Population Health Management.

Is NCT04547374 still recruiting?

NCT04547374 is currently withdrawn. Last updated 19 October 2023.

Last reviewed 2023-10-19 · How we verify

NCT04547374

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Geisinger at Home (GaH) Patient Management

Withdrawn Last updated 19 October 2023

What this trial tests

trial testing GaH Intervention in Population Health Management. Withdrawn.

Timeline

1 April 2021

Primary endpoint
12 July 2021

12 July 2021

Quick facts

Lead sponsor	Geisinger Clinic
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	1 April 2021
Primary completion	12 July 2021
Estimated completion	12 July 2021
Sites	1 location across United States

Drugs / interventions tested

GaH Intervention

Conditions studied

Population Health Management — all drugs for Population Health Management →

Sponsor

Geisinger Clinic

Who can join

18 and older, any sex, with Population Health Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Healthcare cost has increased drastically in the last decade, and over 50% of the cost can be attributed to a small portion (5-10%) of the population. Certain clinical programs, such as home-based care, aim to reduce this utilization but need methods to identify the most appropriate patients to enroll. The Investigators believe that data-driven approaches can optimize this new healthcare delivery system to target patients who may likely benefit from the program. The primary aim of this project is to determine the effectiveness of the Geisinger at Home ™ (GaH) program on survival, emergency department (ED) visits and hospitalizations in multiple patient populations defined by clinical characteristics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Geisinger Clinic trials

Trials by the same sponsor.

NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso · NA · recruiting
NCT06936709 — Perioperative Colchicine for TKA · Phase 4 · not yet recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2 · NA · recruiting
NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04547374 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
Last refreshed: 19 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04547374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing